MedTrace Logo

Misoprostol Prior to Intrauterine Device (IUD) Insertion in Nulliparous Women

NCT01307111 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 85

Last updated 2016-03-28

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to see if using misoprostol makes the intrauterine device insertion easier and less painful in women who have never had a baby.

Conditions

Interventions

DRUG

Misoprostol

400 micrograms inserted buccally or vaginally, per the participants desire prior to the IUD insertion.

DRUG

Placebo

Pills which are identical to the study drug in appearance, taste, and smell.

Sponsors & Collaborators

  • University of New Mexico

    lead OTHER

Principal Investigators

  • Eve Espey, MD/MPH · University of New Mexico Department of Obstetrics and Gynecology

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
14 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-02-28
Primary Completion
2013-02-28
Completion
2013-03-31

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01307111 on ClinicalTrials.gov